Lotux, a venture capital firm focused on investing in early-stage startups in Latin America, has officially closed its second fund with the goal of continuing to back visionary founders with purpose and ambition who seek to change the region through building technology.
Mat Gantar, managing partner at Lotux, told Contxto that Lotux is focused on partnering with mission-driven founders building pre-seed stage, software-based companies that aim to improve the lives of Latin Americans.
With five investments already made with this new fund, Lotux plans to invest in and back another 15 startups over the next 18 months.
Lotux is looking for pre-seed stage startups in industries such as finance, insurance, logistics, e-commerce, education and healthcare, Gantar specified. The ticket they will receive will be between $50,000 to $100,000.
“We are convinced that the most scalable and impactful companies in Latin America are being built by founders committed to improving people’s lives,” Gantar said. “This second fund reaffirms our mission to identify and exponentiate founders from their startups and help them generate momentous impact in the region.”
Since its founding in 2019, the VC firm has established itself as a key player in the Latin American entrepreneurial ecosystem thanks to its strong network of founders, venture partners, and co-investors. This approach has allowed them to have early access to outstanding opportunities and to partner with extraordinary entrepreneurs from the early stages of development.
Commitment to Latin America
To date, Lotux has invested in more than 17 promising startups. Over six years, it has received and analyzed more than 4,000 investment opportunities, selecting only the most outstanding teams, representing less than 1% of the total evaluated.
Lotux has supported startups such as:
Clivi
A digital platform that helps patients in Latin America manage chronic diseases, starting with diabetes and obesity. Clivi patients receive 24/7 continuous care and guidance via WhatsApp to help them live longer, healthier and happier lives. Clivi has already impacted the lives of more than 10,000 patients and in the last year has grown by more than 500%.
“The fund has proven to be a partner with a great appetite for investing in tomorrow’s winners, always guided by the vision of creating value for its portfolio companies,” explains Ricardo Moguel, co-founder and CEO of Clivi.
Anyone AI
Anyone AI trains software developers from all over Latin America to specialize in artificial intelligence (AI). Its programs combine hands-on projects, mentoring from industry experts and a community of peers with a common goal: to accelerate their AI careers. With a selective admissions process and a curriculum focused on solving real industry challenges, it has helped more than 600 developers transform their careers in machine learning and artificial intelligence, actively building the largest AI talent hub in the region.
Threads
Threads is an end-to-end solution for WhatsApp with API access, multi-agent inbox and code-free automations that integrate with all the other tools an enterprise uses. In April, the company’s acquisition by ActiveCampaign, a US company, was announced.
Ximple
This startup is revolutionizing financial access in Latin America by empowering millions of independent sellers with innovative financial and business solutions. To date, Ximple has already provided more than 10,000 loans and impacted more than 10,000 allied sellers through its program and has raised a financing line of $30 million U.S. dollars.
PROSPERiA
An artificial intelligence platform for the early detection of visual diseases in Latin America. Through retinIA, they have performed more than 100,000 evaluations with a sensitivity greater than 93%, allowing large-scale screening without the need for specialists and improving access to preventive care in high-risk populations. They currently work with partners such as AXA Keralty, Bayer and Clinicas del Azúcar, bringing timely detection to primary care settings, occupational health and cardiometabolic clinics.
“What we value most about Lotux’s support is the close accompaniment of their team: in every monthly call we find concrete ideas, valuable connections, useful resources and, when needed, empathetic listening. More than an investor, Lotux has been an ally that really looks out for the best interest of the company and actively seeks how to drive it forward,” said Cristina Campero, co-founder and CEO of PROSPERiA.
During its trajectory, Lotux has detected early on promising startups that are transforming the future of innovation in Latin America.
